| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $32.3M | +27.1% |
| Cost of Revenue | $17.5M | +29.3% |
| Gross Profit | $14.8M | +24.7% |
| R&D Expense | $4.1M | -20.8% |
| SG&A Expense | $4.5M | +34.3% |
| Operating Income | $5.1M | +140.9% |
| Interest Expense | $192K | -26.1% |
| Pre-tax Income | $6.3M | +52.1% |
| Income Tax | -$1.7M |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.5M | +167.3% |
| Accounts Receivable | $3.1M | -12.5% |
| Inventory | $6.7M | +34.5% |
| Current Assets | $18.9M | +54.7% |
| Total Assets | $35.1M | +34.2% |
| Current Liabilities | $6.7M | +15.2% |
| Long-term Debt | $1.4M | -7.5% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.5M | +103.8% |
| Investing Cash Flow | -$499K | -89.7% |
| Financing Cash Flow | -$667K | +23.3% |
| — |
| Net Income | $8.9M | +74.9% |
| EPS (Basic) | $0.01 | +0.0% |
| EPS (Diluted) | $0.01 | +0.0% |
| Total Liabilities |
| $9.9M |
| -1.1% |
| Stockholders' Equity | $25.2M | +56.2% |